RE: No Dx Strategy????28 Mar 2023 18:06
A quarterly bond payment for launch, without guidance to the market for what the actual plan is, will continue to nail investors to the floor. That’s the brutal truth here. We’re weeks away from the next one. AACR…. Bond payment. Without a strategy from AS we will not get over £2, unless we get some sort of license deal. Are we trying to license anything? Are we putting Affimers in diagnostics? How are our other partnerships? What has or is the £100m plus raised in the last 3 years paid/paying for? Would not buying launch and using the bond to accelerate AVA6000 through clinic have made more sense? An RNS would clear up everything.